Literature DB >> 28349640

Developmental trajectories for young children with 16p11.2 copy number variation.

Raphael Bernier1, Caitlin M Hudac1, Qixuan Chen2, Chubing Zeng2, Arianne Stevens Wallace1, Jennifer Gerdts1, Rachel Earl1, Jessica Peterson1, Anne Wolken1, Alana Peters1, Ellen Hanson3,4, Robin P Goin-Kochel5, Stephen Kanne6, LeeAnne Green Snyder7, Wendy K Chung8.   

Abstract

Copy number variation at 16p11.2 is associated with diverse phenotypes but little is known about the early developmental trajectories and emergence of the phenotype. This longitudinal study followed 56 children with the 16p11.2 BP4-BP5 deletion or duplication between the ages of 6 months and 8 years with diagnostic characterization and dimensional assessment across cognitive, adaptive, and behavioral domains. Linear mixed modeling revealed distinct developmental trajectories with deletions showing VIQ gains but declines in motor and social abilities while duplications showed VIQ gains and steady development across other domains. Nonparametric analyses suggest distinct trajectories and early cognitive abilities for deletion carriers who are ultimately diagnosed with intellectual disability and developmental coordination disorder as well as distinct trajectories and early social communication and cognitive abilities for duplication carriers diagnosed with ASD and intellectual disability. Findings provide predictions for patient developmental trajectories, insight into mean functioning of individuals with 16p11.2 at early ages, and highlight the need for ongoing monitoring of social and motor functioning and behavioral symptomatology to improve treatment planning.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  16p11.2 deletion; 16p11.2 duplication; autism spectrum disorder; copy number variation

Mesh:

Year:  2017        PMID: 28349640     DOI: 10.1002/ajmg.b.32525

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

Review 1.  Genomic Disorders in Psychiatry-What Does the Clinician Need to Know?

Authors:  Chelsea Lowther; Gregory Costain; Danielle A Baribeau; Anne S Bassett
Journal:  Curr Psychiatry Rep       Date:  2017-09-20       Impact factor: 5.285

2.  A normative chart for cognitive development in a genetically selected population.

Authors:  Jacob Vorstman; Elemi J Breetvelt; Ania M Fiksinski; Carrie E Bearden; Anne S Bassett; René S Kahn; Janneke R Zinkstok; Stephen R Hooper; Wanda Tempelaar; Donna McDonald-McGinn; Ann Swillen; Beverly Emanuel; Bernice Morrow; Raquel Gur; Eva Chow; Marianne van den Bree; Joris Vermeesch; Stephen Warren; Michael Owen; Therese van Amelsvoort; Stephan Eliez; Doron Gothelf; Celso Arango; Wendy Kates; Tony Simon; Kieran Murphy; Gabriela Repetto; Damian Heine Suner; Stefano Vicari; Joseph Cubells; Marco Armando; Nicole Philip; Linda Campbell; Sixto Garcia-Minaur; Maude Schneider; Vandana Shashi
Journal:  Neuropsychopharmacology       Date:  2021-03-29       Impact factor: 8.294

Review 3.  Progress in Understanding and Treating SCN2A-Mediated Disorders.

Authors:  Stephan J Sanders; Arthur J Campbell; Jeffrey R Cottrell; Rikke S Moller; Florence F Wagner; Angie L Auldridge; Raphael A Bernier; William A Catterall; Wendy K Chung; James R Empfield; Alfred L George; Joerg F Hipp; Omar Khwaja; Evangelos Kiskinis; Dennis Lal; Dheeraj Malhotra; John J Millichap; Thomas S Otis; Steven Petrou; Geoffrey Pitt; Leah F Schust; Cora M Taylor; Jennifer Tjernagel; John E Spiro; Kevin J Bender
Journal:  Trends Neurosci       Date:  2018-04-23       Impact factor: 13.837

Review 4.  Clinical evaluation of patients with a neuropsychiatric risk copy number variant.

Authors:  Samuel Jra Chawner; Cameron J Watson; Michael J Owen
Journal:  Curr Opin Genet Dev       Date:  2021-01-15       Impact factor: 4.665

5.  Refining the Phenotype of Recurrent Rearrangements of Chromosome 16.

Authors:  Serena Redaelli; Silvia Maitz; Francesca Crosti; Elena Sala; Nicoletta Villa; Luigina Spaccini; Angelo Selicorni; Miriam Rigoldi; Donatella Conconi; Leda Dalprà; Gaia Roversi; Angela Bentivegna
Journal:  Int J Mol Sci       Date:  2019-03-04       Impact factor: 5.923

6.  Genetic Control of Expression and Splicing in Developing Human Brain Informs Disease Mechanisms.

Authors:  Rebecca L Walker; Gokul Ramaswami; Christopher Hartl; Nicholas Mancuso; Michael J Gandal; Luis de la Torre-Ubieta; Bogdan Pasaniuc; Jason L Stein; Daniel H Geschwind
Journal:  Cell       Date:  2019-10-17       Impact factor: 66.850

7.  Longitudinal report of child with de novo 16p11.2 triplication.

Authors:  Arianne S Wallace; Caitlin M Hudac; Kyle J Steinman; Jessica L Peterson; Trent D DesChamps; Michael H Duyzend; Xander Nuttle; Evan E Eichler; Raphael A Bernier
Journal:  Clin Case Rep       Date:  2017-12-06

8.  R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice.

Authors:  Laura J Stoppel; Tatiana M Kazdoba; Melanie D Schaffler; Anthony R Preza; Arnold Heynen; Jacqueline N Crawley; Mark F Bear
Journal:  Neuropsychopharmacology       Date:  2017-10-06       Impact factor: 7.853

9.  Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorder.

Authors:  Olafur O Gudmundsson; G Bragi Walters; Andres Ingason; Stefan Johansson; Tetyana Zayats; Lavinia Athanasiu; Ida Elken Sonderby; Omar Gustafsson; Muhammad S Nawaz; Gudbjorn F Jonsson; Lina Jonsson; Per-Morten Knappskog; Ester Ingvarsdottir; Katrin Davidsdottir; Srdjan Djurovic; Gun Peggy Strømstad Knudsen; Ragna Bugge Askeland; Gyda S Haraldsdottir; Gisli Baldursson; Pall Magnusson; Engilbert Sigurdsson; Daniel F Gudbjartsson; Hreinn Stefansson; Ole A Andreassen; Jan Haavik; Ted Reichborn-Kjennerud; Kari Stefansson
Journal:  Transl Psychiatry       Date:  2019-10-17       Impact factor: 6.222

10.  Reversal of synaptic and behavioral deficits in a 16p11.2 duplication mouse model via restoration of the GABA synapse regulator Npas4.

Authors:  Benjamin Rein; Tao Tan; Fengwei Yang; Wei Wang; Jamal Williams; Freddy Zhang; Alea Mills; Zhen Yan
Journal:  Mol Psychiatry       Date:  2020-02-25       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.